ASCO 2026 Embargoed Virtual Press Briefing Today 3:30-5:00 PM ET — Late-Breaking Abstracts Pre-Meeting Reveal Ahead of Saturday May 30 Presentations
ASCO holds its embargoed virtual press briefing for credentialed media today Tuesday May 26 from 3:30-5:00 PM ET. The briefing previews Late-Breaking Abstracts (LBAs) being presented Saturday May 30 at the Annual Meeting opening Friday May 29 in Chicago. LBA embargoes lift at 7:00 AM CT / 8:00 AM ET on the day of scientific presentation. Notable previewed material includes Abstract 3143 (the 12,112-patient real-world GLP-1 cancer metastasis analysis), the ARACOG (AFT-47) randomized clinical trial on cognitive effects of darolutamide vs enzalutamide, and additional peptide-oncology data from the previously-announced cohort. The May 26 briefing is the first formal media-access opportunity for LBA data and feeds directly into Wednesday-Thursday cycle press coverage that bridges into the meeting opening Friday.